Predict your next investment

Ingenza company logo
Corporation
HEALTHCARE | Biotechnology
ingenza.com

See what CB Insights has to offer

Investments

2

Partners & Customers

4

Service Providers

2

About Ingenza

Ingenza, a biocatalyst and bioprocess development company, provides technology to manufacture chiral chemicals and biopharmaceuticals.

Ingenza Headquarter Location

Roslin Innovation Centre, Charnock Bradley Building Easter Bush Campus, Bush Farm Road

Roslin, Scotland, EH25 9RG,

United Kingdom

+44(0)131 651 9681

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ingenza Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ingenza Rank

Latest Ingenza News

Ingenza receives grants to develop new biofuels technology

Feb 16, 2021

Scientist Louis Marlow Ingenza has been awarded two Innovate UK Sustainable Innovation Fund grants amounting to £232,000 (€266,000). The first grant will allow Ingenza to invest in the commercialisation of production technology targeting the bioethanol yeast market, which is worth over £300 million (€344 million) a year globally. This project is based on REDOX chemistry manipulation and has the potential to generate substantial technology license income for Ingenza, underpinning job protection and the company’s investment in future growth initiatives. The second grant, valued at £60,000 (€68,000), will fund the development of innovative synthetic biology approaches to improve the sustainability and cost effectiveness of ethanol production for biofuels and alcoholic beverages. Phase one will evaluate the feasibility of novel engineered Saccharomyces to convert energy from molecular hydrogen into cellular reducing power, while a larger-scale phase two project will test commercial viability, scalability and replicability of this technology. Ingenza’s chief business officer Dr David McElroy said: “It’s fantastic to see Innovate UK recognising SMEs like Ingenza, highlighting our role in addressing the issue of greenhouse gas emissions through the development of novel industrial biotechnologies.” Innovate UK, as part of UK Research and Innovation, is currently investing up to £191 million (€219 million) to fund research and development projects with the aim of helping all sectors of the UK rebuild after the effects of COVID-19. Innovate UK executive chair Dr Ian Campbell added: “In these difficult times, we have seen the best of British business innovation. Ingenza’s bold vision is an important step forward in driving sustainable economic development, while helping to realise the ambitions of hard-working people.” Scientist Louis Marlow

Ingenza Investments

2 Investments

Ingenza has made 2 investments. Their latest investment was in ProFactor Pharma as part of their Unattributed on September 9, 2019.

CBI Logo

Ingenza Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/30/2019

Unattributed

ProFactor Pharma

$2.46M

No

2

8/20/2013

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/30/2019

8/20/2013

Round

Unattributed

Series A

Company

ProFactor Pharma

Subscribe to see more

Amount

$2.46M

$99M

New?

No

Subscribe to see more

Co-Investors

Sources

2

10

Ingenza Partners & Customers

4 Partners and customers

Ingenza has 4 strategic partners and customers. Ingenza recently partnered with Syngenta on December 12, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

12/4/2018

Licensee

Syngenta

Switzerland

Syngenta exercises licensing option for enabling technology from Ingenza

Our partnership with Ingenza helps us develop innovative crop protection products and the success of the collaboration highlights how well the teams from Syngenta and Ingenza work together ; we look forward to continuing our relationship . ''

1

10/3/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/17/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

7/22/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

12/4/2018

10/3/2018

10/17/2017

7/22/2015

Type

Licensee

Partner

Partner

Partner

Business Partner

Syngenta

Country

Switzerland

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Syngenta exercises licensing option for enabling technology from Ingenza

Our partnership with Ingenza helps us develop innovative crop protection products and the success of the collaboration highlights how well the teams from Syngenta and Ingenza work together ; we look forward to continuing our relationship . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Ingenza Service Providers

2 Service Providers

Ingenza has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Commercial Bank

General Business Banking

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Subscribe to see more

Provider Type

Commercial Bank

Subscribe to see more

Service Type

General Business Banking

Subscribe to see more

Partnership data by VentureSource

Ingenza Team

3 Team Members

Ingenza has 3 team members, including current Founder, Managing Director, Ian Fotheringham.

Name

Work History

Title

Status

Ian Fotheringham

Founder, Managing Director

Current

Jaymin Amin

Chief Operating Officer

Current

Jaymin Amin

Chief Operating Officer

Current

Name

Ian Fotheringham

Jaymin Amin

Jaymin Amin

Work History

Title

Founder, Managing Director

Chief Operating Officer

Chief Operating Officer

Status

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.